Associate Engagement Lead – Technology
About the job
- The candidate must have 3–5 years of experience in pharmaceutical technology consulting, including at least 2 years in the United States.
- The candidate must have at least 2 years of experience with cloud platforms including Amazon Web Services, Google Cloud Platform, or Microsoft Azure, as well as client service delivery.
- The candidate must have strong programming skills in Java, C#, Apache Spark, PySpark, and Unix shell or Perl scripting, plus DevOps experience on Amazon Web Services.
- The candidate must have an AWS Solutions Architect – Professional certification, AWS Big Data certification, and AWS Artificial Intelligence/Machine Learning certifications.
- The candidate must have an advanced degree, specifically an MBA or Master's in Engineering, with a strong academic record.
- The candidate must have expertise in metadata management tools, data governance, and master data management.
- Lead cloud transformation initiatives by assessing client information technology landscapes, building business cases, and executing software modernization and infrastructure migrations across Amazon Web Services, Microsoft Azure, and Google Cloud Platform.
- Drive end-to-end project delivery by managing cross-functional teams and overseeing all phases from planning through execution, with a focus on scalability and impact.
- Design and implement secure, compliant cloud solutions, stay current with emerging technologies, and align architectures with industry best practices.
- Translate business requirements into technical strategies and deliver actionable solutions that address real-world challenges and maximize business value.
- Build and maintain strong client partnerships, ensure high-quality service delivery, and align solutions with strategic goals.
- AWS Solutions Architect – Professional certification is preferred.
- AWS Big Data and Artificial Intelligence/Machine Learning certifications are preferred.
About the company
ProcDNA focuses on commercial analytics and technology consulting for life sciences and biopharma. It helps clients turn data into actionable insights through analytics, technology, and data science services, including specialized offerings like Auxo HCP 360 for data management, marketing, and customer relationship optimization. The company delivers tailored solutions in areas such as commercial planning, market assessment, and patient journey quantification, enabling precise business decisions and growth. What sets ProcDNA apart is its deep expertise in market access analytics, sales strategy, and campaign ROI, backed by a leadership team with over a century of combined experience, a track record with 25 clients across 40 disease indications, and a presence in five office locations. The overarching goal is to drive growth for biopharma clients by turning complex data into clear, strategic actions.
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
South San Francisco, California
Founded
2019
Get referred to ProcDNA
See people who can refer or advise you
Simplify's Take
What believers are saying
- August 2026 Bengaluru expansion signals demand for more delivery capacity and client work.
- March 16, 2026 Reuters Pharma presence supports lead generation across commercial and medical functions.
- June 2026 Business Circle recognition strengthens recruiting and enterprise credibility with biopharma clients.
What critics are saying
- ProcDNA disclosed no funding, creating dependence on services revenue and sales execution.
- Glassdoor's 2025 reviews showed 58% recommendation and 2.4 work-life balance, pressuring retention.
- A Veeva or conference-intelligence imitation from Accenture, IQVIA, or ZS erodes differentiation by 2027.
What makes ProcDNA unique
- ProcDNA's 2026 Veeva Services Partner status deepens execution credibility with life sciences buyers.
- Its January 2026 Conference Intelligence package spans oncology, neurology, dermatology, cardiology, and endocrinology.
- ProcDNA reached 400-plus professionals across eight locations by January 2026.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Hybrid Work Options